Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Background A previous analysis in this trial showed that among patients with severe,
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …

Background Severe tricuspid regurgitation is a debilitating condition that is associated with
substantial morbidity and often with poor quality of life. Decreasing tricuspid regurgitation …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Tricuspid Regurgitation | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Valvular regurgitation represents an important cause of cardiovascular morbidity and
mortality. Imaging is pivotal in the evaluation of native valve regurgitation and …

Background Tricuspid regurgitation is common in patients with severe degenerative mitral
regurgitation. However, the evidence base is insufficient to inform a decision about whether …